Search Bar & Filters
Found 6 Actively Recruiting clinical trials
Actively Recruiting
Researchers are collecting detailed information about patients with venous thromboembolism VTE to improve understanding of this condition, especially in groups often excluded from clinical trials such as pregnant women, elderly patients, and those with severe health issues. This observational registry aims to provide data that can help reduce death rates, recurrences of blood clots, bleeding problems, and arterial events related to VTE. This study gathers clinical details about each patient, including other health conditions, and tracks the type, dose, duration, and results of antithrombotic treatments over the first three months. The registry is accessible online to assist doctors in managing complex cases by comparing patient profiles and identifying those at higher risk of complications. Participants clinical status and treatment outcomes are recorded, focusing on recurrence of VTE, bleeding events, and mortality over a three-year period. The information supports the creation of predictive scores to help healthcare providers identify patients at higher risk. The study started in 2001 and plans to continue until 2027, with ongoing data collection and follow-up.
Actively Recruiting
Researchers are studying whether ultrasound-guided alcohol sclerotherapy can reduce pelvic pain and improve quality of life in women aged 18 to 45 diagnosed with ovarian endometriomas, compared to expectant management. Endometriosis is a common condition causing chronic pelvic pain and fertility issues, with ovarian endometrioma being the most frequent form. This trial aims to clarify if sclerotherapy offers better symptom relief and quality of life improvements than simply monitoring the condition. Participants will be randomly assigned to either receive ultrasound-guided alcohol sclerotherapy, where the cyst is punctured and treated with alcohol for 15 minutes followed by a wash, or to a control group receiving expectant management with standard pain care if needed. The study will compare these groups over 6 months, focusing on pain levels, quality of life, and fertility outcomes. During the study, participants will complete pain and quality of life assessments at the start and after 6 months. They will also provide blood and urine samples for biomarker analysis and undergo tests to assess ovarian reserve. Researchers will monitor adverse events, recurrence, pregnancy rates over about 2 years, and healthcare costs. The study uses rigorous analysis methods to assess the benefits and risks of the treatment.
Actively Recruiting
Researchers are evaluating the effectiveness of the PIPPEP digital platform in improving treatment adherence and clinical outcomes for young adults aged 18 to 40 who are receiving early intervention for psychosis. This trial aims to assess whether adding the PIPPEP platform to usual care helps patients stick to their psychosocial and pharmacological treatments better. The study also looks at the platforms cost-effectiveness, its reach among patients, and effects on symptoms, medication side effects, social stigma, risk, comorbid symptoms, and social functioning. Participants are randomly assigned to one of two groups. One group receives usual care plus access to the PIPPEP platform, which provides educational content, regular self-assessment questionnaires, two-way messaging with the care team, and gamified rewards. The control group receives usual care without the platform. Questionnaires are completed at the start, six months, and twelve months, with some completed weekly. The intervention program includes multidisciplinary care with psychiatric, nursing, social work, and psychological support for up to five years. Participants will be monitored throughout the study with assessments at baseline, six months, and twelve months. These include adherence to treatment, costs, symptom impact, medication side effects, cognitive insight, substance use, anxiety and depression, social stigma, quality of life, and overall functioning. Data from questionnaires completed via the platform are securely stored in medical records. The study aims to improve engagement and prognosis by combining digital tools with personalized follow-up in early psychosis care.
Actively Recruiting
Healthy Volunteer
Researchers are evaluating an eHealth platform called ePro-Schools designed to promote physical activity, healthy eating, and reduce sedentary behavior among adolescents from socially disadvantaged backgrounds in Central Catalonia. The study aims to address gaps in public health policies by co-designing the platform with adolescents, school staff, and policymakers. This randomized controlled trial will assess the programs effectiveness, cost-effectiveness, and implementation in six secondary schools with around 1000 adolescent participants. The intervention includes two digital platforms an Intervention Platform containing interactive modules for students and physical education teachers, and an Information Platform with educational resources for students, teachers, and families. The program will be delivered during one school year 202526 through web-based access. Schools are randomized into an intervention group receiving full access to the platform and a control group receiving only basic health-related information, with the control group gaining access to the full platform after the trial. Participants will be evaluated at baseline, post-intervention, and nine months after post-intervention for physical activity levels, sedentary behavior, and dietary habits, which are the primary outcomes. Secondary outcomes include physical fitness, water consumption, quality of life, depressive symptoms, social isolation, and sleep quality. The study also involves surveys, questionnaires, interviews, and focus groups to monitor adoption, acceptability, and feasibility. The total participation covers the school year and follow-up period with continuous engagement and data collection.
Actively Recruiting
Researchers are evaluating the clinical and cost-effectiveness of two ways to deliver mindfulness-based cognitive therapy MBCT for adults with recurrent depression, either during an acute episode or in remission. The study compares MBCT delivered through eight weekly videoconference group sessions and a self-help manual combined with three low-intensity videoconference group support sessions against usual mental health outpatient care in Spain. The trial aims to identify factors influencing response and explore psychological mechanisms of change over a 12-month follow-up period. Participants will be randomly assigned to one of three groups group MBCT delivered via videoconference over eight weekly 2-hour sessions, supported MBCT self-help involving a workbook with three one-hour videoconference support sessions, or treatment as usual TAU provided in routine clinical practice. The interventions are led by trained therapists and include home practice or self-guided exercises. The study uses a parallel design with double blinding and is conducted at multiple centers within the Spanish National Health System. During the study, participants will be assessed at baseline, post-treatment, and at 6- and 12-month follow-ups. Measures include transitions between depression states, symptom severity, mental well-being, quality of life, and healthcare costs. Researchers will also evaluate mindfulness, positive affect, and self-compassion. The study collects data through questionnaires, clinical ratings, and interviews to understand participant experiences and the broader impact of MBCT delivery formats on depression relapse prevention.
Actively Recruiting
Fibromyalgia is a common syndrome that currently has no cure and results in significant healthcare and societal costs. Researchers are investigating the effectiveness, physiological effects, and cost-utility of a self-guided digital intervention called STANZA-Spain, which is based on Acceptance and Commitment Therapy ACT for adults diagnosed with fibromyalgia. This trial is a six-month, three-arm randomized controlled study recruiting 360 adults who meet the 2016 American College of Rheumatology criteria for fibromyalgia. Participants will be randomly assigned to one of three groups Treatment as usual TAU plus the STANZA digital ACT app, TAU plus a digital symptom tracking app called FibroST, or TAU alone. The STANZA app offers 41 structured ACT lessons designed to be completed in 8 weeks, followed by 4 weeks of maintenance. FibroST provides daily symptom tracking and educational materials without psychotherapy. TAU involves usual care by general practitioners and specialists, including consultations, advice, and medications. Throughout the study, participants will be assessed at baseline, after treatment, and at 6 months follow-up. Assessments include functional impairment using the Fibromyalgia Impact Questionnaire Revised FIQR, patient impressions of change, measures of depression, anxiety, stress, cognitive impairment, and pain catastrophizing. Immune-inflammatory biomarkers will be collected at baseline and post-treatment in a subset of participants. Researchers will also conduct a qualitative analysis to better understand user experiences with the STANZA app. The total study duration for participants is six months.